Short-term efficacy and safety of zoledronate acid or denosumab in Japanese patients with postmenopausal osteoporosis

INTRODUCTION: We aimed to compare the efficacy after switching from either bisphosphonates (BPs) or non-BPs (NBPs) to combination therapies of denosumab (DMAb) or zoledronic acid (Zol) with eldecalcitol (ELD) in bone mineral density (BMD) and bone metabolism and investigate the prognostic and risk f...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Yumejiro, Shimizu, Tomohiro, Asano, Tsuyoshi, Shimodan, Shun, Ishizu, Hotaka, Takahashi, Daisuke, Takahata, Masahiko, Iwasaki, Norimasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021003/
https://www.ncbi.nlm.nih.gov/pubmed/33821302
http://dx.doi.org/10.1007/s00774-021-01221-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021003/
https://www.ncbi.nlm.nih.gov/pubmed/33821302
http://dx.doi.org/10.1007/s00774-021-01221-6

Ejemplares similares